The program includes physician-managed GLP-1 weight loss (semaglutide and tirzepatide), bioidentical hormone replacement therapy via pellet insertion for women and men, NAD+ infusions for cellular health and recovery, and B12/lipotropic injection blends for energy and metabolism support
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand names Ozempic for injection and Rybelsus for oral tablets) and chronic weight management (as Wegovy)
Start your intake How Much Does GLP-1 Treatment Cost Without Insurance
Short-acting GLP-1RAs keep working the same way on stomach emptying over time
Den frste DPP4-hmmer Januvia (sitagliptin) blev godkendt af FDA i 2006 og havde sin debut p det europiske marked ret efter
Collectively, these actions address several of the metabolic consequences that estrogen withdrawal sets in motion, including worsening insulin resistance, dyslipidemia, and chronic low-grade inflammation